Takeda Pharmaceutical Co Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 19.30 M | $309.34 M | 1.01% | 0.61% |
| FMR LLC | 08/13/2026 | 9.60 M | $153.88 M | 34.87% | 0.30% |
| MORGAN STANLEY | 08/13/2026 | 6.99 M | $112.13 M | 8.12% | 0.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 6.05 M | $96.99 M | -5.82% | 0.19% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 5.13 M | $82.15 M | -8.79% | 0.16% |
| BRANDES INVESTMENT PARTNERS, LP | 08/14/2026 | 4.54 M | $72.77 M | 2.45% | 0.14% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 3.73 M | $59.84 M | 19.79% | 0.12% |
| BLACKROCK, INC. | 08/07/2026 | 3.69 M | $59.12 M | 16.11% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 2.57 M | $41.17 M | -14.09% | 0.08% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 2.21 M | $35.39 M | 100.00% | 0.07% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 2.11 M | $33.90 M | 7.30% | 0.07% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 2.05 M | $32.85 M | -21.25% | 0.06% |
| MANAGED ASSET PORTFOLIOS, LLC | 08/06/2026 | 1.82 M | $29.24 M | 1.42% | 0.06% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.74 M | $27.90 M | -11.26% | 0.06% |
| VAN ECK ASSOCIATES CORP | 08/14/2026 | 1.67 M | $26.83 M | -25.93% | 0.05% |
| ENVESTNET ASSET MANAGEMENT INC | 08/03/2026 | 1.60 M | $25.62 M | 13.19% | 0.05% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.53 M | $24.46 M | 70.58% | 0.05% |
| QUANTINNO CAPITAL MANAGEMENT LP | 08/13/2026 | 1.40 M | $22.48 M | 8.79% | 0.04% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 1.15 M | $18.45 M | 1.30% | 0.04% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 1.05 M | $16.84 M | 100.00% | 0.03% |
| UBS GROUP AG | 08/13/2026 | 911.32 K | $14.61 M | -66.74% | 0.03% |
| CROSSMARK GLOBAL HOLDINGS, INC. | 07/16/2026 | 783.84 K | $12.56 M | 0.86% | 0.02% |
| JANE STREET GROUP, LLC | 08/14/2026 | 769.00 K | $12.33 M | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 09/02/2026 | 758.90 K | $12.17 M | -49.73% | 0.02% |
| JPMORGAN CHASE & CO | 08/12/2026 | 744.92 K | $11.90 M | 64.09% | 0.02% |
| STIFEL FINANCIAL CORP | 08/12/2026 | 722.86 K | $11.59 M | 15.00% | 0.02% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 714.14 K | $11.45 M | 275.05% | 0.02% |
| ROYAL BANK OF CANADA | 08/14/2026 | 692.90 K | $11.11 M | 12.69% | 0.02% |
| COLONY GROUP, LLC | 08/12/2026 | 679.95 K | $10.90 M | 40.96% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 619.02 K | $9.92 M | 14.56% | 0.02% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 619.02 K | $9.92 M | 100.00% | 0.02% |
| CREATIVE PLANNING | 08/13/2026 | 584.78 K | $9.37 M | 7.69% | 0.02% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 584.56 K | $9.37 M | 13.43% | 0.02% |
| LPL FINANCIAL LLC | 08/07/2026 | 555.23 K | $8.90 M | 17.09% | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 511.34 K | $8.20 M | 263.74% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 485.73 K | $7.79 M | 55.83% | 0.02% |
| US BANCORP \DE\ | 08/12/2026 | 466.71 K | $7.48 M | -8.53% | 0.01% |
| PFM HEALTH SCIENCES, LP | 08/14/2026 | 444.17 K | $7.12 M | 100.00% | 0.01% |
| BLEAKLEY FINANCIAL GROUP, LLC | 08/05/2026 | 432.96 K | $6.94 M | 0.31% | 0.01% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 408.74 K | $6.55 M | 31.00% | 0.01% |
| CITIGROUP INC | 08/03/2026 | 396.46 K | $6.36 M | 10.69% | 0.01% |
| FEDERATED HERMES, INC. | 08/12/2026 | 376.86 K | $6.04 M | -1.41% | 0.01% |
| QRG CAPITAL MANAGEMENT, INC. | 07/14/2026 | 372.75 K | $5.98 M | 1.38% | 0.01% |
| ETHIC INC. | 07/29/2026 | 365.25 K | $5.85 M | 9.08% | 0.01% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 08/14/2026 | 351.77 K | $5.64 M | 1.72% | 0.01% |
| ASSETMARK, INC | 07/30/2026 | 314.69 K | $5.04 M | 38.25% | 0.01% |
| MARINER, LLC | 08/13/2026 | 308.16 K | $4.94 M | 31.14% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 307.31 K | $4.93 M | -3.96% | 0.01% |
| HRT FINANCIAL LP | 08/14/2026 | 278.71 K | $4.47 M | 121.07% | 0.01% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 275.00 K | $4.41 M | 100.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Takeda Pharmaceutical Co institutional Ownership - FAQ's
During the previous two years, 550 institutional investors and hedge funds held shares of Takeda Pharmaceutical Co. The most heavily invested institutionals were:
Capital Research Global Investors: 19.3 M
FMR LLC: 9.6 M
MORGAN STANLEY: 6.99 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 6.05 M
GOLDMAN SACHS GROUP INC: 5.13 M
BRANDES INVESTMENT PARTNERS, LP: 4.54 M
3.32% of Takeda Pharmaceutical Co stock is owned by institutional investors.
Institutional investors have bought a total of 125.04 M shares in the last 24 months. This purchase volume represents approximately $2.26 B in transactions.